In recent years, the field of brain disease treatment has witnessed technological innovation, with transcranial electromagnetic combined stimulation emerging as a non-invasive neuromodulation technique that has garnered significant attention. This technology, which integrates transcranial electrical stimulation (TES) and transcranial magnetic stimulation (TMS), has gradually become an important means for the treatment and rehabilitation of brain diseases due to its potential synergistic effects. This article will delve into the mechanism, clinical application, and future development direction of transcranial electromagnetic combined stimulation, revealing the potential of this cutting-edge technology for you.

October 29th marks the 20th World Stroke Day. This year's theme is "Recognize Stroke Early, Go to Hospital Immediately!" It aims to raise public awareness of stroke recognition and treatment, urging people to seize the "golden 4.5 hours" to minimize the risk of disability and death.

In the field of modern medicine, cerebral infarction, as a common cerebrovascular disease, has seen an increasing incidence rate in China year by year, posing a serious threat to people's life and health. Atherosclerotic cerebral infarction (ASCI) is an important type among them, and its pathogenesis is mainly due to insufficient blood supply to local brain tissue caused by atherosclerosis, leading to ischemic and hypoxic necrosis. The clinical manifestations include limb paralysis, hemibody numbness, and loss of language function. If not treated in time, it is highly likely to lead to disability or even death. This article will introduce you in detail to a clinical study on the treatment of ASCI with transcranial ultrasound thrombolysis combined with rosuvastatin, allowing you to gain a deeper understanding of the clinical manifestations of this new treatment regimen.